| tipas : |
Laboratorija |
|
| Mokslinių tyrimų Komandos : |
|
| Autoriai : |
|
| Pavadinimas : |
Atezolizumab (Tecentriq®) - Summary of Product Characteristics |
| Numeris : |
Roche Products Limited 2021 |
|
| Įrodymų lygis : |
|
| fizinis stabilumas : |
|
| Cheminis stabilumas : |
|
| Kiti metodai : |
|
| Komentarai : |
|
Junginių sąrašas
 Atezolizumab
|
 |
 |
 |
 |
3.2 >> 16.8 mg/ml |
2-8°C |
 |
| 30 |
 |
|
|
|
|
|
3.2 >> 16.8 mg/ml |
<30°C |
|
| 24 |
 |
|
|
|
 |
|
3.2 >> 16.8 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
3.2 >> 16.8 mg/ml |
<30°C |
|
| 24 |
|
|
|
|
 |
|
3.2 >> 16.8 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
3.2 >> 16.8 mg/ml |
<30°C |
|
| 24 |
|
|
|
|
 |
|
3.2 >> 16.8 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
3.2 >> 16.8 mg/ml |
<30°C |
|
| 24 |
|
|
|
|
|
